Dirk Repsilber
0000-0002-7173-5579
Publication & Citation Trends
Publications
0 total
P0247 A proximity extension assay-based serum assay enabling absolute quantification of prognostic proteins in inflammatory bowel disease: Development and Analytical Validation
Cited by 0
Semantic Scholar
P0088 The exposome metabolome in paediatric inflammatory bowel disease: A cross-sectional study in a population-based Norwegian cohort
Cited by 0
Semantic Scholar
P0510 Non-targeted lipidomic profiling reveals distinct molecular signatures in inflammatory bowel disease: Discovery and validation in two inception cohorts
Cited by 0
Semantic Scholar
OP08 A protein signature for prediction of disease course in newly diagnosed Ulcerative Colitis
Cited by 0
Semantic Scholar
A novel diagnostic serum protein signature for pediatric inflammatory bowel disease.
Cited by 0
Semantic Scholar
OP32 Preclinical Anti-Integrin αvβ6 Autoantibodies in Ulcerative Colitis: Validation of Predictive Performance, Early Life Emergence and Environmental Modifiers across Multiple Population-Based Cohorts
Cited by 0
Semantic Scholar
OP04 NORDTREAT: a randomised, multicentre, biomarker-strategy design, open-label, controlled trial of top-down versus clinical management in newly diagnosed IBD
Cited by 0
Semantic Scholar
Transcriptional modulation unique to vulnerable motor neurons predicts ALS across species and SOD1 mutations OA
Cited by 3
Semantic Scholar
Research Topics
Inflammatory Bowel Disease
(37)
Gene expression and cancer classification
(32)
Gut microbiota and health
(29)
Bioinformatics and Genomic Networks
(20)
Microscopic Colitis
(19)
Affiliations
Uppsala University
Max Planck Society
University of Potsdam
Örebro University
Jožef Stefan Institute